Research news from the AGA

November 01, 2004

Bethesda, Maryland (Nov. 1, 2004) - Two studies published today show that widespread use of virtual colonoscopy will ultimately decrease demand for traditional colonoscopy and increase colorectal cancer screening rates, and "prepless" virtual colonoscopy is as effective as the traditional method of colorectal cancer screening. These studies were published in the American Gastroenterological Association (AGA) journal Gastroenterology.

Colorectal cancer is the second-leading cause of cancer deaths in the United States. Guidelines of multiple agencies and professional societies underscore the importance of colorectal cancer screening for all individuals 50 years of age and older.

Virtual Colonoscopy for Colorectal Cancer Screening Reduces the Number of Traditional Colonoscopies, Researchers Say
(The Impact of CT Colonography on Colonoscopy Demand, Hur et al.)

Some researchers have argued that the widespread use of virtual colonoscopy will lead to an increase in the total number of traditional colonoscopies performed each year, as traditional colonoscopies are necessary to further study the polyps found in patients undergoing the virtual process. However, in this month's issue of Gastroenterology, Harvard researchers say that increased use of virtual colonoscopy will instead lead to a decrease in the number of traditional colonoscopies.

Results of this study suggest that the number of colonoscopies reported could be reduced by 28 percent if virtual colonoscopy was widely implemented. In a previous analysis by the AGA, virtual colonoscopy was found to be a promising treatment with limitations, such as the inability to consistently detect flat polyps or those smaller than one centimeter.

The Harvard study's projected decrease in traditional colonoscopies varied depending on the polyp size "threshold" or the size polyp used to qualify a patient for a follow-up colonoscopy--a larger polyp threshold results in fewer patients being referred for follow-up traditional colonoscopies. This effect is seen mainly because the percentage of people being falsely referred for further screening decreases with a larger polyp threshold.

"The polyp-size threshold is very important when determining who will be required to undergo additional testing for colon cancer," said Chin Hur, MD, MPH, lead study author. "This study underscores the importance of determining what size polyp is clinically significant and warrants further research."

Currently, colorectal screening compliance in the United States among adults ages 50 and older is 40 percent--a figure that could increase to as much as 55 percent upon full implementation of the screening method. However, mass implementation of virtual colonoscopy for colorectal cancer screening is limited by several factors, including the lack of clinical data that proves its efficacy, continued evolution of technology, the fact that the procedure is not reimbursable by insurance and the continued need for bowel preparation.

Researchers: Bowel Preparation Unnecessary with Virtual Colonoscopy
(CT Colonography Without Cathartic Preparation, Iannaccone, et al.)

Another study published in this month's Gastroenterology addresses the purgative bowel preparation process that's necessary before colonoscopies and its impact on patient compliance. This study found virtual colonoscopy without bowel preparation or substantial dietary restrictions to be as effective as traditional colonoscopy (with bowel preparation) in detecting colorectal polyps.

"The elimination of purgative bowel preparation makes virtual colonoscopy a patient-friendly diagnostic test for colorectal cancer," said Riccardo Iannaccone, MD, lead study author. "We hope that the new prepless test will increase rates of screening and early detection for this cancer killer."

If confirmed by other studies, the researchers from this study believe the findings will drive interest in "prepless" procedures and increase virtual colonoscopy's future standing as a viable and perhaps primary screening method for colorectal cancer. On the basis of its high patient compliance, prepless virtual colonoscopy may ultimately increase the total number of patients being screened for colorectal cancer--a current goal of most physicians.

In this study, patients were asked to drink an iodinated contrast agent diluted in water to "tag" fecal matter prior to the procedure. The purpose of this substance is to provide a way for the professional performing the procedure to distinguish solid and liquid fecal matter from potentially cancerous polyps. Nearly 90 percent of the study participants preferred the fecal tagging regimen prior to virtual colonoscopy over the purgative bowel preparation prior to traditional colonoscopy. Researchers concluded that the use of the tagging strategy, state-of-the-art screening equipment and highly-skilled radiologists contributed to the high ability of the test to detect polyps.

About the Studies

The Impact of CT Colonography on Colonoscopy Demand, Hur et al. Researchers at Harvard Medical School conducted a base-case analysis using estimates from published literature, the Clinical Outcomes Research Initiative (CORI) national endoscopic database and from the Massachusetts General Hospital's endoscopy unit. Current national colonoscopy practice, estimated using various published reports, was used as the foundation to project colonoscopy demand if virtual colonoscopy was implemented as the primary colorectal cancer screening method.

CT Colonography Without Cathartic Preparation, Iannaccone, et al. Researchers from the University of Rome conducted a prospective cohort study on 203 patients 35 years of age or older who underwent low-dose virtual colonoscopy without bowel preparation, and later underwent traditional colonoscopy. The study population consisted of patients who were symptomatic and asymptomatic (48 and 52 percent, respectively). Findings of this study need to be confirmed in a large asymptomatic, average-risk screening population.
About the AGA
The American Gastroenterological Association (AGA) is dedicated to the mission of advancing the science and practice of gastroenterology. Founded in 1897, the AGA is the oldest medical-specialty society in the United States. The AGA's 14,000 members include physicians and scientists who research, diagnose and treat disorders of the gastrointestinal tract and liver. On a monthly basis, the AGA publishes two highly respected journals, Gastroenterology and Clinical Gastroenterology and Hepatology. The AGA's annual meeting is Digestive Disease Week, which is held each May and is the largest international gathering of physicians, researchers and academics in the fields of gastroenterology, hepatology, endoscopy and gastrointestinal surgery.

About Gastroenterology
Gastroenterology, the official journal of the AGA, is the most prominent journal in the subspecialty and is in the top one percent of indexed medical journals internationally. The journal publishes clinical and basic studies of all aspects of the digestive system, including the liver and pancreas, as well as nutrition. The journal is abstracted and indexed in Biological Abstracts, CABS, Chemical Abstracts, Current Contents, Excerpta Medica, Index Medicus, Nutrition Abstracts and Science Citation Index.

American Gastroenterological Association

Related Colorectal Cancer Articles from Brightsurf:

Colorectal cancer treatment: the winning combinations
Chemotherapy has distressing side effects for patients and increases the risk of developing resistance to the treatment.

A new model to predict survival in colorectal cancer
This signature could be useful in clinical practice, especially for colorectal cancer diagnosis and therapy.

Roadmap to reducing colorectal cancer deaths
The American Gastroenterological Association has outlined a strategy to increase the number of people screened via tests that are more convenient, accurate and less expensive and tailored to people's individual cancer risks.

Study provides new insight on colorectal cancer growth
A new study by researchers at the University of Kentucky identifies a novel function of the enzyme spermine synthase to facilitate colorectal cancer growth.

Researchers ID target for colorectal cancer immunotherapy
Researchers at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center have identified a target for colorectal cancer immunotherapy.

Colorectal cancer partner-in-crime identified
A protein that helps colorectal cancer cells spread to other parts of the body could be an effective treatment target.

Cancer cell reversion may offer a new approach to colorectal cancer treatment
A novel approach to reverse the progression of healthy cells to malignant ones may offer a more effective way to eradicate colorectal cancer cells with far fewer side effects, according to a KAIST research team based in South Korea.

A novel pathway to target colorectal cancer
Survival rates for patients with late-stage colorectal cancer are dismal, and new therapeutic strategies are needed to improve outcomes.

Colorectal cancer rates in Canada
The incidence of colorectal cancer among younger adults increased in recent years in this analysis of data from Canadian national cancer registries that included about 688,000 new colorectal cancers diagnosed over more than 40 years.

Cancer drugs promote stem cell properties of colorectal cancer
Scientists from the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) and the Mannheim University Medical Center have now discovered that a certain group of cancer drugs (MEK Inhibitors) activates the cancer-promoting Wnt signalling pathway in colorectal cancer cells.

Read More: Colorectal Cancer News and Colorectal Cancer Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to